Skip to content
  • Mon. Nov 16th, 2026

Wall Street 2 Bay Street

  • Energy
  • Business
  • Technology
  • Podcast Interviews
  • Wall Street News
  • About Us
  • Contact Us

Latest Post

VivoSim Labs and Chemveda Move Human-Tissue Testing Earlier in AI Drug Development Graphene Manufacturing (OTCQX: GMGMF) Expands Across Europe and Mexico, See What’s Next Why IBRX, VIVS and PDSB Now? Immunotherapy, Human Tissue Testing and More Tech Inside Emerging Stocks: VRDR, BIOF, AMFN Spotlight CleanTech, Energy, Plus More Inside Blue Biofuels (OTCQB: BIOF): Why Now Low-Carbon Renewable Fuels in Focus
Business

VivoSim Labs and Chemveda Move Human-Tissue Testing Earlier in AI Drug Development

November 13, 2026 admin
Business

Graphene Manufacturing (OTCQX: GMGMF) Expands Across Europe and Mexico, See What’s Next

November 12, 2026 admin
Business

Why IBRX, VIVS and PDSB Now? Immunotherapy, Human Tissue Testing and More Tech Inside

November 10, 2026 admin
Business

Emerging Stocks: VRDR, BIOF, AMFN Spotlight CleanTech, Energy, Plus More Inside

November 10, 2026 admin
Business

Blue Biofuels (OTCQB: BIOF): Why Now Low-Carbon Renewable Fuels in Focus

November 9, 2026 admin
VivoSim Labs and Chemveda Move Human-Tissue Testing Earlier in AI Drug Development
Business
VivoSim Labs and Chemveda Move Human-Tissue Testing Earlier in AI Drug Development
Graphene Manufacturing (OTCQX: GMGMF) Expands Across Europe and Mexico, See What’s Next
Business
Graphene Manufacturing (OTCQX: GMGMF) Expands Across Europe and Mexico, See What’s Next
Why IBRX, VIVS and PDSB Now? Immunotherapy, Human Tissue Testing and More Tech Inside
Business
Why IBRX, VIVS and PDSB Now? Immunotherapy, Human Tissue Testing and More Tech Inside
Emerging Stocks: VRDR, BIOF, AMFN Spotlight CleanTech, Energy, Plus More Inside
Business
Emerging Stocks: VRDR, BIOF, AMFN Spotlight CleanTech, Energy, Plus More Inside
VivoSim Labs and Chemveda Move Human-Tissue Testing Earlier in AI Drug Development
Business
VivoSim Labs and Chemveda Move Human-Tissue Testing Earlier in AI Drug Development
Walmart’s Entry Could Spark Heavy Interest in These Crypto/Metaverse Stocks
Crypto
Walmart’s Entry Could Spark Heavy Interest in These Crypto/Metaverse Stocks
Metaverse Stocks to Watch: DIS, NSAV, GYST, MWWC
Crypto
Metaverse Stocks to Watch: DIS, NSAV, GYST, MWWC
American Manganese Inc (OTCQB:AMYZF) (TSXV:AMY) Stock Watchlist After Progress Update
Technology
American Manganese Inc (OTCQB:AMYZF) (TSXV:AMY) Stock Watchlist After Progress Update
VivoSim Labs and Chemveda Move Human-Tissue Testing Earlier in AI Drug Development
Business
VivoSim Labs and Chemveda Move Human-Tissue Testing Earlier in AI Drug Development
Graphene Manufacturing (OTCQX: GMGMF) Expands Across Europe and Mexico, See What’s Next
Business
Graphene Manufacturing (OTCQX: GMGMF) Expands Across Europe and Mexico, See What’s Next
Why IBRX, VIVS and PDSB Now? Immunotherapy, Human Tissue Testing and More Tech Inside
Business
Why IBRX, VIVS and PDSB Now? Immunotherapy, Human Tissue Testing and More Tech Inside
Emerging Stocks: VRDR, BIOF, AMFN Spotlight CleanTech, Energy, Plus More Inside
Business
Emerging Stocks: VRDR, BIOF, AMFN Spotlight CleanTech, Energy, Plus More Inside
Business

Greenland Stocks in Focus: GLND, GRML, CRML Lead the Watchlist More Names Inside

September 21, 2026 admin

Sept. 21, 2026 Greenland-linked stocks are drawing heightened investor attention following President Donald Trump’s announcement of a new security framework involving the United States, Denmark and Greenland. Described by Trump…

Business

VivoSim Labs Inc. (NASDAQ: VIVS) Takes Aim at Pharma’s 92% Drug-Failure Problem

September 18, 2026 admin

Sept. 18, 2026 Approximately 92% of drugs entering clinical trials fail before receiving regulatory approval, leaving the pharmaceutical industry with a success rate of only about 8%. VivoSim Labs Inc.…

Business

High-Impact Stocks DRK, VIVS, AEMD, GMG in the News

September 17, 2026 admin

Sept. 17, 2026 Investors are watching DarkHorse Technologies Inc. (NASDAQ: DRK), VivoSim Labs, Inc. (NASDAQ: VIVS) and Graphene Manufacturing Group Ltd. (TSXV: GMG) (OTCQX: GMGMF) following developments across AI infrastructure,…

Business

PullBack Stocks PDSB, PRSO, IGC, RETO: Who Breaks First?

September 15, 2026 admin

Sept. 15, 2026 Small-cap stocks PDS Biotechnology Corporation (NASDAQ: PDSB), IGC Pharma, Inc. (NYSE: IGC), Peraso Inc. (NASDAQ: PRSO) and ReTo Eco-Solutions, Inc. (NASDAQ: RETO) are in focus following recent…

Business

Small-Cap Stocks VEEA ANY MEDS MYSZ Watch Now

September 15, 2026 admin

Sept. 15, 2026 Investors looking across emerging-growth and small-cap stocks are watching Veea Inc. (NASDAQ: VEEA), Sphere 3D Corp. d/b/a DarkHorse Technologies (NASDAQ: ANY), DataMEDS AI, Inc. (NASDAQ: MEDS), MySize,…

Business

Catch the Danger, Spare the Cure: Why VivoSim’s (NASDAQ: VIVS) 90%/95% Toxicity Results Matter

September 14, 2026 admin

September 14, 2026 In drug development, identifying a dangerous compound is only half the challenge. The other is avoiding the premature elimination of a potentially valuable medicine. VivoSim Labs, Inc.…

Business

Sphere 3D (NASDAQ: ANY) Built for AI Speed as Full-Stack AI Compute Economics Surge

September 14, 2026 admin

Sept. 11, 2026 Sphere 3D Corp. d/b/a DarkHorse Technologies (NASDAQ: ANY) is accelerating its transition toward AI infrastructure, high-performance computing (HPC) and energized data centers, positioning its power portfolio around…

Business

Graphene Manufacturing (TSXV: GMG) (OTCQX: GMGMF) Battery Breakthrough, Asia Expansion Add Major 2026 Catalysts

September 11, 2026 admin

September __, 2026 Graphene Manufacturing Group Ltd. (TSXV: GMG) (OTCQX: GMGMF) is adding new potential catalysts to its 2026 growth story, led by encouraging results from its next-generation G®CELLS graphene…

Business

Sphere 3D (NASDAQ: ANY) Soars After Hours as AI Data Center Expansion Accelerates

September 9, 2026 admin

Sept. 9, 2026 Sphere 3D Corp. d/b/a DarkHorse Technologies (NASDAQ: ANY) enters Wednesday’s trading session in focus after shares surged in after-hours trading Tuesday following major strategic developments aimed at…

Business

VivoSim Labs (NASDAQ: VIVS): Predicting Drug Toxicity Before Human Clinical Trials

September 9, 2026 admin

September 8, 2026 VivoSim Labs, Inc. (NASDAQ: VIVS) is targeting one of pharmaceutical development’s most expensive challenges: identifying drug toxicity before a candidate reaches human clinical trials. Using its NAMkind™…

Posts pagination

1 … 4 5 6 … 139
MARKETS
World markets by TradingView
COMMODITIES
Track all markets on TradingView

Wall Street 2 Bay Street

Proudly powered by WordPress | Theme: Newsup by Themeansar.

  • Disclaimer